『The Lancet Gastroenterology & Hepatology in conversation with』のカバーアート

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with

著者： The Lancet Group
無料で聴く

概要

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

© 2026 The Lancet Group 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection

    Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
    2025/11/28

    Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv
    続きを読む 一部表示
    16 分
  • Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS

    Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
    2025/11/20

    Do wheat or gluten trigger IBS symptoms?

    We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv
    続きを読む 一部表示
    16 分
  • Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma

    Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
    2025/06/19

    Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.

    Read the full article:

    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv
    続きを読む 一部表示
    27 分
まだレビューはありません